Events | Sutro Biopharma, Inc.

Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer

Dec 27, 2021

- Dr. Naumann and Sutro management to discuss interim data on the STRO-002 Phase 1 dose-expansion cohort at Company event scheduled for Wednesday, Jan. 5, 2022 at 5 pm ET, or 2 pm PT SOUTH SAN FRANCISCO, Calif., Dec. 27, 2021 – Sutro Biopharma, Inc. (“Sutro”),...

Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present at ASH 2021

Dec 13, 2021

– Nonclinical data for STRO-002 and STRO-001 are shared in two oral presentations at the 63rd American Society of Hematology Annual Meeting SOUTH SAN FRANCISCO, Calif, Dec. 13, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development...

4th Annual Evercore ISI HeathCONx Conference – Presentation

Nov 30, 2021

Webcast, Nov 30, 2021 at 10:05am EST Download Presentation, Click Here

Piper Sandler 33rd Annual Healthcare Conference – Presentation

Nov 22, 2021

Webcast, Nov 22, 2021 at 10:00am EST Download Presentation, Click here

Sutro Biopharma to Participate in Two Upcoming Investor Conferences

Nov 22, 2021

SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...

Jefferies London Healthcare Conference – Presentation

Nov 17, 2021

Webcast: Nov 18, 2021 at 3:00am EST Download: Click Here

Stifel 2021 Virtual Healthcare Conference – Presentation

Nov 15, 2021

Webcast: Nov 15, 2021 at 1:20pm EST Download: Click Here

Credit Suisse 30th Annual Healthcare Conference – Presentation

Nov 10, 2021

Webcast, Nov 10, 2021 at 4:20pm EST Download Presentation, Click Here

Sutro Biopharma to Participate in Three Upcoming Investor Conferences

Nov 2, 2021

SOUTH SAN FRANCISCO, Calif., Nov. 2, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...